Determinants of CPT-11 and SN-38 activities in human lung cancer cells

British Journal of Cancer
J van Ark-OtteG Giaccone

Abstract

Irinotecan (CPT-11) is a semisynthetic camptothecin derivative with a broad spectrum of anti-tumour activity. Carboxylesterase (CE) catalyses the conversion of CPT-11 to SN-38 (7-ethyl-10-hydroxycamptothecin), the active form of CPT-11. The antiproliferative effects of CPT-11 and SN-38, CE-activity and topoisomerase I protein expression were investigated in five human small-cell lung cancer (SCLC) cell lines and four human non-small-cell lung cancer (NSCLC) cell lines. Antiproliferative activity, expressed as IC50 values, was determined using the MTT assay. CPT-11 was significantly more active in SCLC than in NSCLC cell lines (P = 0.0036), whereas no significant difference between histological types was observed with SN-38. A significant correlation (r2 = 0.52, P = 0.028) was observed between CE activity and chemosensitivity to CPT-11 but not to SN-38, and significantly higher CE activity was observed in SCLC compared with NSCLC cell lines (P = 0.025). Western blotting experiments showed topoisomerase I protein expressions within a factor of 2, and a granular nuclear staining was detectable in all cell lines by immunocytochemistry of cytospins. No correlation was observed between protein expression and sensitivity to CPT-11 or ...Continue Reading

Citations

Nov 4, 2000·Expert Opinion on Investigational Drugs·F P Worden, G P Kalemkerian
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Helen M DoddsLaurent P Rivory
Feb 24, 2001·Annals of the New York Academy of Sciences·L P Rivory
May 14, 2011·Molecular Biology Reports·Gwi-Moon SeoDeryl L Troyer
Jun 5, 2014·BioMed Research International·Nima SepehriRassoul Dinarvand
Aug 12, 2014·World Journal of Gastroenterology : WJG·Mariusz Panczyk
May 8, 2007·Cancer Chemotherapy and Pharmacology·Ricardo BellottJacques Robert
Feb 9, 2008·Pharmacology·Howard R Mellor, Richard Callaghan
Feb 6, 2008·Basic & Clinical Pharmacology & Toxicology·Takenori TakahataShinsaku Fukuda
Jan 24, 2009·International Journal of Cancer. Journal International Du Cancer·Michael KeeseMatthias Löhr
Jun 10, 2011·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Minh-Tâm BaylatryAlex Laurent
Sep 1, 2005·Pharmaceutical Research·Quan TianShufeng Zhou
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Michael, M M Doherty
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Roberta MagriniChristoph Hanski
Nov 25, 2011·Proceedings of the National Academy of Sciences of the United States of America·Shingo HatakeyamaMichiko N Fukuda
Mar 27, 2015·Veterinary and Comparative Oncology·C E BoudreauP J Dickinson
Apr 14, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Kei IrieShoji Fukushima
Dec 1, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hakan AkbulutAlbert Deisseroth
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wendy L AllenPatrick G Johnston
Dec 17, 2010·Cancer Research·Salomé PaillasCéline Gongora
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John BoyerPatrick G Johnston
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Euan C RamsayMarcel B Bally
Apr 4, 2021·Cancers·Diego CortinovisAlessandro Morabito
Dec 17, 2002·Critical Reviews in Oncology/hematology·Christian Bailly
Feb 25, 2006·Journal of Pharmaceutical and Biomedical Analysis·Yong-Xing ZhaoWen-Quan Liang
Dec 7, 2018·Molecular Pharmaceutics·Hyungjun KimSangyong Jon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.